Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes

A randomized, double-blind, placebo-controlled study

Marc Rendell, Steven G. Chrysant

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)183-186
Number of pages4
JournalPostgraduate Medicine
Volume123
Issue number4
DOIs
StatePublished - Jul 2011

Fingerprint

Metformin
Type 2 Diabetes Mellitus
Placebos
Safety
Therapeutics
Linagliptin

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes : A randomized, double-blind, placebo-controlled study. / Rendell, Marc; Chrysant, Steven G.

In: Postgraduate Medicine, Vol. 123, No. 4, 07.2011, p. 183-186.

Research output: Contribution to journalArticle

@article{73ce5b0043294948bb6e150db4e19759,
title = "Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study",
author = "Marc Rendell and Chrysant, {Steven G.}",
year = "2011",
month = "7",
doi = "10.3810/pgm.2011.07.2318",
language = "English",
volume = "123",
pages = "183--186",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "4",

}

TY - JOUR

T1 - Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes

T2 - A randomized, double-blind, placebo-controlled study

AU - Rendell, Marc

AU - Chrysant, Steven G.

PY - 2011/7

Y1 - 2011/7

UR - http://www.scopus.com/inward/record.url?scp=79960320108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960320108&partnerID=8YFLogxK

U2 - 10.3810/pgm.2011.07.2318

DO - 10.3810/pgm.2011.07.2318

M3 - Article

VL - 123

SP - 183

EP - 186

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 4

ER -